← All transactions
SurgAR: €11M Series A from Bpifrance, XAnge, Elaia
Exclusive advisor to the company
- Date
- Aug 2024
- Sector
- Healthcare
- Business
- 3D surgical registration
- Transaction
- €11M Series A from Bpifrance, XAnge, Elaia
- Apparius’s role
- Exclusive advisor to the company
- Area of focus
- Surgical robotics and navigation
SurgAR develops augmented reality solutions for minimally invasive surgery. Closed just before CE marking of its first product, dedicated to uterine surgery, the round will accelerate its rollout in hospitals and the build-up of clinical data.